Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta 2-microglobulin is not a bone cell mitogen.

J C Jennings1, S Mohan, D J Baylink

  • 1Department of Medicine, Loma Linda University School of Medicine, California.

Endocrinology
|July 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Local administration of AAV-DJ pseudoserotype expressing COX2 provided early onset of transgene expression and promoted bone fracture healing in mice.

Gene therapy·2015
Same author

Production, recovery, and purification of synnematin A and B.

Antibiotics & chemotherapy (Northfield, Ill.)·2014
Same author

Effect of synnematin B treatment of Salmonella infections in mice and chicks.

Antibiotics & chemotherapy (Northfield, Ill.)·2014
Same author

The bactericidal action of synnematin B.

Antibiotics & chemotherapy (Northfield, Ill.)·2014
Same author

CASES ILLUSTRATING THE EFFECTS OF THE WARM BATH IN ASPHYXIA.

Association medical journal·2010
Same author

Ether v. Chloroform.

British medical journal·2010
Same journal

Zingerone ameliorates ovarian impairment by regulating steroidogenesis and apoptosis in letrozole-treated mouse.

Endocrinology·2026
Same journal

Loss of the calorie restriction response protein DEPP1 worsens diet-induced obesity.

Endocrinology·2026
Same journal

Long Non-Coding RNAs Mediate Endocrine Signaling and Resistance in Prostate Cancer.

Endocrinology·2026
Same journal

Repeated Chemogenetic Activation of C1 Catecholamine Neurons Reduces Subsequent Glucoprivic Responses and Mimics HAAF.

Endocrinology·2026
Same journal

Postnatal exposure to maternal hypothyroidism leads to developmental delay and metabolic dysregulations in male mice.

Endocrinology·2026
Same journal

Discovery proteomics identification of factors contributing to gonadotropin β expression.

Endocrinology·2026
See all related articles

Bovine beta 2-microglobulin (beta 2M) isolated from bone matrix extracts showed mitogenic activity for osteoblast-like cells. However, this activity was attributed to transforming growth factor-beta (TGF beta) contamination, not an intrinsic property of beta 2M.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Bone Biology

Background:

  • Bone matrix contains various growth factors influencing osteoblast proliferation.
  • Beta 2-microglobulin (beta 2M) is a protein found in various biological fluids and tissues.
  • Previous studies suggested potential mitogenic roles for matrix components.

Purpose of the Study:

  • To purify and identify a mitogenic peptide from bovine bone matrix extracts.
  • To determine if beta 2-microglobulin (beta 2M) possesses intrinsic mitogenic activity for osteoblast-like cells.
  • To investigate the source of mitogenic activity observed in beta 2M preparations.

Main Methods:

  • Purification of peptides from EDTA extracts of bovine bone matrix using chromatography.
  • Amino-terminal amino acid sequencing to identify the purified peptide.

Related Experiment Videos

  • Mitogenic assays using cultured osteoblast-like cells and [3H] methylthymidine incorporation.
  • Characterization of biological activity using reducing agents and antibodies.

    • Main Results:

    • A peptide identified as bovine beta 2-microglobulin (beta 2M) was purified and showed mitogenic activity.
    • The mitogenic activity of beta 2M was significantly lower than purified growth factors and comparable to crude extracts.
    • Evidence strongly suggested that the observed mitogenic activity was due to transforming growth factor-beta (TGF beta) contamination.
    • Biological activity was abolished by reducing agents and neutralized by anti-TGF beta antibodies.

    Conclusions:

    • Beta 2-microglobulin (beta 2M) present in bovine bone matrix extracts is not intrinsically mitogenic for osteoblast-like cells.
    • The mitogenic activity associated with purified beta 2M preparations is attributable to contaminating transforming growth factor-beta (TGF beta).
    • This study clarifies the role of beta 2M in bone cell proliferation, distinguishing it from potent mitogens like TGF beta.